A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Rhonda Pacheco to succeed Julie Kim, who was appointed to be Takeda’s next CEO
The products include high-quality, advanced anti-infective formulations such as EMROK (Levonadifloxacin) and MIQNAF (Nafithromycin)
Maria Soler Nunez appointed as Chief Quality Officer
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
CGX-926 is the first clinical candidate addressing MC4R-deficient genetic obesity
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
RTX001 represents a groundbreaking advance in the treatment of end-stage liver disease, offering new hope for patients with limited options
Subscribe To Our Newsletter & Stay Updated
